Scholar Rock Holding (SRRK) Current Deferred Revenue (2017 - 2021)

Scholar Rock Holding (SRRK) recorded quarterly Current Deferred Revenue of $33.2 million in Q4 2021, down 10.87% quarter-over-quarter from $37.2 million in Q3 2021, and up 76.41% on a YoY basis from $18.8 million in Q4 2020.

Scholar Rock Holding (SRRK) Current Deferred Revenue (2017 - 2021) Analysis & Trends

Scholar Rock Holding's Current Deferred Revenue history runs 5 years deep, the most recent figure standing at $33.2 million for Q4 2021.

  • In Q4 2021, Current Deferred Revenue rose 76.41% year-over-year to $33.2 million; the TTM figure through Dec 2021 stood at $33.2 million (up 76.41% YoY), while the FY2021 annual figure was $33.2 million, up 76.41% from the prior year.
  • Current Deferred Revenue was $33.2 million for Q4 2021 at Scholar Rock Holding, down from $37.2 million in the prior quarter.
  • In the past five years, Current Deferred Revenue ranged from a high of $47.3 million in Q1 2021 to a low of $228000.0 in Q4 2017.
  • Historically, Current Deferred Revenue has averaged $24.5 million across 5 years, with a median of $20.6 million in 2019.
  • The sharpest annual moves came in 2018 and 2020: Current Deferred Revenue surged 8763.6% in 2018, then slumped 35.84% in 2020.
  • A 5-year view of Current Deferred Revenue shows it stood at $228000.0 in 2017, then soared by 8763.6% to $20.2 million in 2018, then advanced by 3.53% to $20.9 million in 2019, then declined by 10.07% to $18.8 million in 2020, then soared by 76.41% to $33.2 million in 2021.
  • The last three Current Deferred Revenue figures came in at $33.2 million (Q4 2021), $37.2 million (Q3 2021), and $42.7 million (Q2 2021), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Alterity Therapeutics 925,601.88 Bn 925,601.85 Bn -
2 Belite Bio 58,560.00 Bn 58,560.00 Bn -
3 Quantum Biopharma 17,284.41 Bn 17,284.40 Bn -
4 Legend Biotech 2,809.00 Bn 2,808.71 Bn 242.10 Mn
5 Evaxion A 1,334.43 Bn 1,334.42 Bn -
6 Akari Therapeutics 1,312.27 Bn 1,312.26 Bn -
7 Psyence Biomedical 212.16 Bn 212.16 Bn -
8 Vertex Pharmaceuticals 114.83 Bn 107.58 Bn 2.59 Bn
9 Abivax 91.96 Bn 91.96 Bn -
10 Scholar Rock Holding 6.03 Bn 5.55 Bn -

Historic Data

Download Data
DateValue
Dec 31, 2021 33.19 Mn
Sep 30, 2021 37.24 Mn
Jun 30, 2021 42.71 Mn
Mar 31, 2021 47.30 Mn
Dec 31, 2020 18.82 Mn
Sep 30, 2020 16.71 Mn
Jun 30, 2020 20.36 Mn
Mar 31, 2020 16.27 Mn
Dec 31, 2019 20.92 Mn
Sep 30, 2019 20.25 Mn
Jun 30, 2019 23.52 Mn
Mar 31, 2019 25.36 Mn
Dec 31, 2018 20.21 Mn
Dec 31, 2017 228,000.00